The Patent Finder

Sprout Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Sprout Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Sprout Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,227,476Use of Flibanserin in the Treatment of Obesity
Term ended
Term ended Jul 31, 2026 · High confidence
Term endedTerm ended Jul 31, 2026High confidence
US 8,785,458Use of Flibanserin in the Treatment of Obesity
Term ended
Term ended Jul 31, 2026 · High confidence
Term endedTerm ended Jul 31, 2026High confidence
US 9,730,927Use of Flibanserin in the Treatment of Obesity
Term ended
Term ended Jul 31, 2026 · High confidence
Term endedTerm ended Jul 31, 2026High confidence
US 10,335,407Use of flibanserin in the treatment of obesity
Term ended
Ended no later than Jul 31, 2026 · From the USPTO record
Term endedEnded no later than Jul 31, 2026From the USPTO record
US 10,874,668Use of Flibanserin in the treatment of obesity
Term ended
Ended no later than Jul 31, 2026 · From the USPTO record
Term endedEnded no later than Jul 31, 2026From the USPTO record
US 10,596,170Treatment of vasomotor symptoms
Lapsed on the fee record
Ended Mar 24, 2024 · From the USPTO record
Lapsed on the fee recordEnded Mar 24, 2024From the USPTO record
US 8,227,471Treating Sexual Desire Disorders with Flibanserin
Term ended
Ended no later than Oct 22, 2023 · Medium confidence
Term endedEnded no later than Oct 22, 2023Medium confidence
US 7,923,449Benzimidazolone Derivatives for the Treatment of Premenstrual and Other Female Sexual Disorders
Lapsed on the fee record
Ended Apr 12, 2023 · High confidence
Lapsed on the fee recordEnded Apr 12, 2023High confidence
US 7,183,410Stable Polymorph of Flibanserin
Term ended
Term ended Oct 30, 2022 · High confidence
Term endedTerm ended Oct 30, 2022High confidence
US 9,468,639Treating Sexual Desire Disorders with Flibanserin
Term ended
Term ended Oct 16, 2022 · Low confidence
Term endedTerm ended Oct 16, 2022Low confidence
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited